Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
European Journal of Heart Failure
|
June 1, 2005
The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study
Alex Zaphiriou, Stephen Robb, Tarita Murray-Thomas, et al.
Trials
|
January 25, 2014
An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes--the MID-Frail study: study protocol for a randomised controlled trial
Leocadio Rodríguez-Mañas, Antony J Bayer, Mark Kelly, et al.
Frontiers in Pharmacology
|
February 2, 2018
EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management
Luc Van Bortel, Hildegard Sourgens, Kerstin Breithaupt-Grögler, et al.
Current Protocols in Toxicology
|
October 6, 2010
Use of medaka in toxicity testing
Stephanie Padilla, John Cowden, David E Hinton, et al.
Heart (British Cardiac Society)
|
July 10, 2009
Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK
P A Mehta, S W Dubrey, H F McIntyre, et al.
European Journal of Heart Failure
|
October 8, 2008
Mode of death in patients with newly diagnosed heart failure in the general population
Paresh A Mehta, Simon W Dubrey, Hugh F McIntyre, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
|
January 20, 2009
Aquatic animal models of human disease: selected papers and recommendations from the 4th Conference
David E Hinton, Ron C Hardman, Seth W Kullman, et al.
Frontiers in Pharmacology
|
December 28, 2020
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges
Shahzadgai Khan, Muna Albayaty, James Bush, et al.
BMJ Open
|
April 3, 2025
Qualitative study to inform the design and contents of a patient-reported symptom-based risk stratification system for patients referred from primary care on a suspected head and neck cancer diagnostic pathway
Abigail Albutt, Lynn McVey, Rebecca Randell, et al.
Frontiers in Pharmacology
|
December 5, 2018
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development
Susan Reijntjes, Muna Albayaty, James Bush, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
European Journal of Heart Failure
|
June 1, 2005
The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study
Alex Zaphiriou, Stephen Robb, Tarita Murray-Thomas, et al.
Trials
|
January 25, 2014
An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes--the MID-Frail study: study protocol for a randomised controlled trial
Leocadio Rodríguez-Mañas, Antony J Bayer, Mark Kelly, et al.
Frontiers in Pharmacology
|
February 2, 2018
EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management
Luc Van Bortel, Hildegard Sourgens, Kerstin Breithaupt-Grögler, et al.
Current Protocols in Toxicology
|
October 6, 2010
Use of medaka in toxicity testing
Stephanie Padilla, John Cowden, David E Hinton, et al.
Heart (British Cardiac Society)
|
July 10, 2009
Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK
P A Mehta, S W Dubrey, H F McIntyre, et al.
European Journal of Heart Failure
|
October 8, 2008
Mode of death in patients with newly diagnosed heart failure in the general population
Paresh A Mehta, Simon W Dubrey, Hugh F McIntyre, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
|
January 20, 2009
Aquatic animal models of human disease: selected papers and recommendations from the 4th Conference
David E Hinton, Ron C Hardman, Seth W Kullman, et al.
Frontiers in Pharmacology
|
December 28, 2020
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges
Shahzadgai Khan, Muna Albayaty, James Bush, et al.
BMJ Open
|
April 3, 2025
Qualitative study to inform the design and contents of a patient-reported symptom-based risk stratification system for patients referred from primary care on a suspected head and neck cancer diagnostic pathway
Abigail Albutt, Lynn McVey, Rebecca Randell, et al.
Frontiers in Pharmacology
|
December 5, 2018
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development
Susan Reijntjes, Muna Albayaty, James Bush, et al.
Page
of 14